Current Drug Targets
Title:Editorial [Hot Topic: Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention Part II: Pharmacogenomics and Biotechnological Applications of Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention]
Volume: 7 Issue: 4
Author(s): Thomas Efferth
Affiliation:
Export Options
About this article
Cite this article as:
Efferth Thomas, Editorial [Hot Topic: Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention Part II: Pharmacogenomics and Biotechnological Applications of Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention], Current Drug Targets 2006; 7 (4) . https://dx.doi.org/10.2174/138945006776359386
DOI https://dx.doi.org/10.2174/138945006776359386 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Near-infrared Light Responsive Polymeric Nanocomposites for Cancer Therapy
Current Topics in Medicinal Chemistry Preface
Drug Delivery Letters Double-Strand Breaks Repair by Non-Homologous DNA End Joining in Mammalian Cells
Current Genomics Molecular Bases of Chemoresistance in Cholangiocarcinoma
Current Drug Targets Acid-extrusion from Tissue: The Interplay Between Membrane Transporters and pH Buffers
Current Pharmaceutical Design Bacterial Siderophores and Their Potential Applications: A Review
Current Molecular Pharmacology Risk Stratification of Dyslipidemia: Insights from the Framingham Study
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Synthesis and Biochemical Evaluation of a Range of 4-(n-alkanesulfonate) benzyl Imidazole-Based Compounds as Inhibitors of Rat Testicular 17α-hydroxylase/17,20-lyase (P450<sub>17α</sub>) in the Treatment of Hormone- Dependent Prostate Cancer
Letters in Drug Design & Discovery HSF1 as a Cancer Biomarker and Therapeutic Target
Current Cancer Drug Targets Development of a Registry for Down Syndrome in the Gulf Area of the Middle East
Applied Clinical Research, Clinical Trials and Regulatory Affairs HLA Class I Expression, Tumor Escape and Cancer Progression
Current Cancer Therapy Reviews Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
Current Cancer Drug Targets Cordycepin Affects Multiple Apoptotic Pathways to Mediate Hepatocellular Carcinoma Cell Death
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents
Current Pharmaceutical Design Meet Our Editorial Board Member
Combinatorial Chemistry & High Throughput Screening Targeting Plasmodium Falciparum Purine Salvage Enzymes: A Look At Structure-Based Drug Development
Infectious Disorders - Drug Targets Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Current Drug Metabolism Targeting Tumors with Small Molecule Peptides
Current Cancer Drug Targets Stearoyl-CoA Desaturase: A Vital Checkpoint in the Development and Progression of Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets